Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer

AIM: To determine the efficacy of bevacizumab in patients with metastatic colorectal cancer (MCRC) who have failed prior chemotherapy without bevacizumab. METHODS: Between March 2002 and June 2010, 40 patients in South Korea with MCRC who were treated with bevacizumab plus chemotherapy as a second o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Park, Lee Chun, Lee, Ho Sup, Shin, Seong Hoon, Park, Seun Ja, Park, Moo In, Oh, Sung Yong, Kwon, Hyuk Chan, Baek, Jin ho, Choi, Young Jin, Kang, Myoung Joo, Kim, Yang Soo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Co., Limited 2012
Konular:
Brief Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3296985/
https://ncbi.nlm.nih.gov/pubmed/22416186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i10.1104
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller